www.fdanews.com/articles/159731-fda-approves-novo-nordisk-hemophilia-a-drug
FDA Approves Novo Nordisk Hemophilia A Drug
October 17, 2013
The FDA has granted Novo Nordisk a clear path for its biologics license for the hemophilia A drug Novoeight.
Pharma Times
Pharma Times